Demographic, Physiologic and Radiographic Characteristics of COPD Patients Taking Chronic Systemic Corticosteroids

References

• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Bethesda, MD: National Heart, Lung, and Blood Institute, April 2001 (revised 2009). (Available at http://www.goldcopd.org).
   Google Scholar
• Regan E, Hokanson J, Murphy J, Make B, Lynch D, Beaty T, Genetic epidemiology of COPD (COPDGene®) study design. COPD 2010; 7:32–43.
   PubMedGoogle Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:179–187.
   PubMed Web of Science ®Google Scholar
• Pellefrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Series “ATS/ERS Task Force: Standardisation of lung function testing”. Eur Respir J 2005; 26:948–968.
   PubMedGoogle Scholar
• Celli BR, Cote CG, Marin JM, Casanova C, de Oca MM, Mendez RA, The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. NEJM 2004; 350:1005–1012.
   PubMed Web of Science ®Google Scholar
• ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111–117.
   PubMed Web of Science ®Google Scholar
• Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8:1398–1420.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Wright EC, Hodgkin JE, and the IPPB Trial Group. Prognosis in chronic obstructive pulmonary disease. Am Rev Resp Dis 1986; 133:14–20.
   PubMed Web of Science ®Google Scholar
• Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease: a 15-year follow-up study. Am Rev Respir Dis 1979; 119:895–902.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 1221:1434–1440.
   Google Scholar
• Wegner RE, Jorres RA, Kirsten DK, Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994; 7:725–729.
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med. 2006; 173:1326–1334.
   PubMed Web of Science ®Google Scholar
• Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23:28–33.
   PubMed Web of Science ®Google Scholar
• Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167:544–49.
   PubMed Web of Science ®Google Scholar
• Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest 2007; 131:696–704.
   PubMed Web of Science ®Google Scholar
• Seemungal TAR, Donaldson GC, Bhowmik A, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:1608–1618.
   PubMed Web of Science ®Google Scholar
• Sachs APE, Koeter GH, Groenier KH, van der Waaij D, Schiphuis J, Jong BM. Changes in symptoms, peak expiratory flow and sputum glora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. Thorax 50:758–763.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57:847–852.
   PubMed Web of Science ®Google Scholar
• Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr., Desbiens N, Fulkerson WJ, Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996; 154:959–967.
   PubMed Web of Science ®Google Scholar
• Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, Chronic obstructive pulmonary disease stage and health-related quality of life: the quality of life of chronic obstructive pulmonary disease study group. Ann Int Med 1997; 127:1072–1079.
   PubMed Web of Science ®Google Scholar
• Seemungal TAR, Donaldson GC, Paul EA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1418–1422.
   PubMed Web of Science ®Google Scholar
• Gan WQ, Man SFP, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59:574–580.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TAR, Patel IS, Bhowmik A, Wilkinson TMA, Hurst JR, Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005; 128:1995–2004.
   PubMed Web of Science ®Google Scholar
• Seemuungal TA, Wilkinson TAM, Hurst JR, Perera WR, Sapsford RJ, Wedzicha JA. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 2008; 178:1139–1147.
   PubMed Web of Science ®Google Scholar
• van Gestel YR, Hoeks SE, Sin DD, Simsek C, Weltzen G, Schouten O, Stam H, Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease. Am J Cardiol 2008; 102:192–196.
   PubMed Web of Science ®Google Scholar
• Brightling CE, Monteiro W, Ward R, Parker D, Morgan MDL, Wardlaw AJ, Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 2000; 356:1480–1485.
   PubMed Web of Science ®Google Scholar
• Walters JAE, Walters EH, Wood-Baker R. Oral corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2005; 3. Art No: CD005374.
   Web of Science ®Google Scholar
• Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155:542–548.
   PubMed Web of Science ®Google Scholar